DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

(Rule 14a-101)

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.     )

 

 

Filed by the Registrant  x                            Filed by a Party other than the Registrant  ¨

Check the appropriate box:

 

¨   Preliminary Proxy Statement
¨   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨   Definitive Proxy Statement
x   Definitive Additional Materials
¨   Soliciting Material under § 240.14a-12

Agios Pharmaceuticals, Inc.

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

 

x   No fee required.
¨   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

¨   Fee paid previously with preliminary materials.
¨   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

     

  (2)  

Form, Schedule or Registration Statement No.:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

 


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Stockholder Meeting to Be Held on June 21, 2016.

 

AGIOS PHARMACEUTICALS, INC.        

Meeting Information            

   
               Meeting Type:     Annual Meeting    
               For holders as of:     April 22, 2016    
              

Date:    June 21, 2016

 

      Time: 9:00 AM Eastern Time

   
              

Location:   The Company’s office

   
              

  88 Sidney Street

   

                    AGIOS PHARMACEUTICALS, INC.

                    88 SIDNEY STREET

                    ATTN: MIN WANG

                    CAMBRIDGE, MA 02139-4137

       

  Cambridge, MA 02139

   
                        

LOGO

      You are receiving this communication because you hold shares in the company named above.
     

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

     

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

         

See the reverse side of this notice to obtain proxy materials and voting instructions.


       

Before You Vote  

        
                
                

How to Access the Proxy Materials

 

           

 

Proxy Materials Available to VIEW or RECEIVE:

   

      

         

NOTICE AND PROXY STATEMENT         2015 ANNUAL REPORT TO STOCKHOLDERS        

 

How to View Online:

Have the information that is printed in the box marked by the arrow   LOGO   (located on the following page) and visit: www.proxyvote.com.

 

How to Request and Receive a PAPER or E-MAIL Copy:

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

                               1) BY INTERNET:         www.proxyvote.com

                               2) BY TELEPHONE:     1-800-579-1639

                               3) BY E-MAIL*:             sendmaterial@proxyvote.com

*  If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow   LOGO  (located on the following page) in the subject line.

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before June 7, 2016 to facilitate timely delivery.

 

   
                 
       

How To Vote  

        
                
                

Please Choose One of the Following Voting Methods

                 

LOGO

         

Vote In Person: Many stockholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow   LOGO  (located on the following page) available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

   
                 


                 Voting items                           
   

Proposals - The Board of Directors recommends

a vote FOR the director nominees in Proposal 1,

FOR Proposals 2 and 4 and “1 Year” for Proposal 3:

 

         
             
   

1.     Election of Directors

 

         
   

        Nominees:

 

              
   

        01)    David P. Schenkein, M.D.

        02)    Robert T. Nelsen         

        03)    Marc Tessier-Lavigne, Ph.D.

    
          
    2.     To approve an advisory vote on named executive officer compensation.     
    3.    To hold an advisory vote on the frequency of future advisory votes on named executive officer compensation.     
    4.    To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2016.     
    NOTE: The proxies are authorized to vote, in their discretion, upon such other business as may properly come before the meeting or any adjournment or postponement thereof.     
          
          
          
LOGO         
        
        
        


               
               
               
               
               
               
               
               
               
               
               

 

LOGO

               

LOGO